Fibrosis improvement with pegozafermin treatment in mash patients with f4 fibrosis: analysis from a 24-week randomized, double- blind, placebo- controlled phase 2 trial ( enliven)

HEPATOLOGY(2023)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要